simvastatin has been researched along with Hypertension, Renal in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Bae, E; Han, SW; Kim, JE; Kim, YS; Lee, S; Moon, JJ; Park, DJ; Yang, SH; Yu, MY | 1 |
Agrotis, A | 1 |
Chade, AR; Grande, JP; Krier, JD; Lerman, A; Lerman, LO; Zhu, XY | 1 |
Liu, DH; Tang, YB; Wang, M; Xue, SJ; Zhang, Z | 1 |
DellĂȘ, H; Fujihara, CK; Malheiros, DM; Mantovani, E; Mattar, AL; Noronha, IL; Rodrigues, LT; Vieira, JM; Zatz, R | 1 |
5 other study(ies) available for simvastatin and Hypertension, Renal
Article | Year |
---|---|
Renoprotective Effect of KLF2 on Glomerular Endothelial Dysfunction in Hypertensive Nephropathy.
Topics: Angiotensin II; Animals; Atherosclerosis; Endothelial Cells; Fibrosis; Humans; Hypertension, Renal; Interleukin-18; Kruppel-Like Transcription Factors; Mice; Nephritis; RNA, Messenger; Simvastatin; Transcription Factors | 2022 |
Simvastatin, an inhibitor of epithelial-to-mesenchymal transition in experimental atherosclerotic renovascular disease?
Topics: Animals; Atherosclerosis; Epithelial Cells; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Renal; Mesenchymal Stem Cells; Simvastatin | 2008 |
Simvastatin abates development of renal fibrosis in experimental renovascular disease.
Topics: Animals; Atherosclerosis; Blood Pressure; Disease Models, Animal; Epithelial Cells; Fibrosis; Glomerular Filtration Rate; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Renal; Mesenchymal Stem Cells; Renal Artery Obstruction; Renal Circulation; Simvastatin; Sus scrofa | 2008 |
Simvastatin ameliorates angiotensin II-induced endothelial dysfunction through restoration of Rho-BH4-eNOS-NO pathway.
Topics: Acetylcholine; Angiotensin II; Animals; Biopterins; Blood Pressure; Carotid Arteries; Cells, Cultured; Endothelial Cells; Endothelium, Vascular; GTP Cyclohydrolase; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Renal; Nitric Oxide; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley; rho-Associated Kinases; Simvastatin; Vasodilation | 2012 |
Statin monotherapy attenuates renal injury in a salt-sensitive hypertension model of renal disease.
Topics: Albuminuria; Animals; Cell Division; Chemokine CCL2; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Disease Models, Animal; Enzyme Inhibitors; Extracellular Matrix; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Renal; Lymphocytes; Macrophages; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Wistar; RNA, Messenger; Simvastatin; Sodium Chloride; Transforming Growth Factor beta | 2005 |